Category: Investor updates

Appendix 4D, Half-year report of 30th June, 2019, has been lodged with the Australian Securities Exchange. View Appendix 4D Half-year report.

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B, for the quarter ended 30 June 2018 is posted. View and download Appendix 4C

“Form 604 notice of changes of interests of substantial holder” is posted. View and download Form 604 notice of changes of interests of substantial holder.

“Appendix 3B New issue announcement, application for quotation of additional securities and agreement” of 19 June, 2018 is posted. View and download Appendix 3B New

“Appendix 3Y Change of Director’s Interest Notice” is posted. View and download “Appendix 3Y Change of Director’s Interest Notice“.

“Notice Pursuant to Section 708A(5)(e) of the Corporations Act” is posted. View and download Notice Pursuant to Section 708A(5)(e) of the Corporations Act.

“Appendix 3B, New issue announcement, application for quotation of additional securities and agreement” of 6th June, 2018, is posted. View and download Appendix 3B, New issue

Viriathus Research has published a 29-page Overview Report on Imagion Biosystems Limited. This detailed report includes close examinations of the company’s business and investment potential,

In accordance with Listing Rule 3.10A, Imagion Biosystems Limited (the Company) advises that 3,483,333 fully paid ordinary shares in the Company, which are unquoted and